Article

Screening and identification of MSX1 for predicting progestin resistance in endometrial cancer

2020-03-16

Abstract excerpt

<title>Abstract</title> <p>Background: Progestin resistance is a critical obstacle for endometrial conservative therapy. Therefore, the studies to acquire a more comprehensive understanding of the mechanisms and specific biomarkers to predict progestin resistance are very important. However, the pivotal roles of essential molecules of progestin resistance are still unexplored. <h4>Methods:</h4> We downloaded GSE1...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 5217bb26-9040-5151-9142-bc1ab0f0b8db
DOI: 10.21203/rs.3.rs-17361/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Screening and identification of MSX1 for predicting progestin resistance in endometrial cancerDOI 10.21203/rs.3.rs-17361/v1Read

Identification of candidate biomarkers associated with the diagnosis and prognosis of endometrial cancer: a bioinformatics analysisSemantic proximity Read

Identification of Candidate Biomarkers Associated With the Diagnosis and Prognosis of Endometrial Cancer ：A Bioinformatics Analysis IdentifiesSemantic proximity Read

Eleven genes associated with progression and prognosis of endometrial cancer (EC) identified by comprehensive bioinformatics analysisSemantic proximity Read

Identification of molecular markers associated with the progression and prognosis of endometrial cancer: a bioinformatic studySemantic proximity Read

YAP/TAZ reverse progestin resistance through PI3K-Akt pathway in endometrial carcinomaSemantic proximity Read

Identification of Key Candidate Genes and Pathways in Endometrial Cancer by Integrated Bioinformatical AnalysisSemantic proximity Read

Bioinformatic screening for candidate biomarkers and their prognostic values in endometrial cancerSemantic proximity Read

Hsa-circ-0001860 promotes Smad7 to enhance MPA resistance in endometrial cancer via miR-520hSemantic proximity Read

Identification of aberrantly methylated differentially expressed genes and associated pathways in endometrial cancer using integrated bioinformatic analysisSemantic proximity Read

TCGA and Experimental Validation-Based Analysis of the SPRR2A Gene's Expression and Clinical Relevance in Endometrial CancerSemantic proximity Read

Relationship between insulin resistance and endometrial cancer was revealed by gene screeningSemantic proximity Read

Integrated Analysis of Multiple Microarrays Based on Raw Data Identified Novel Gene Signatures in Recurrent Implantation FailureSemantic proximity Read